Latest Nebulizer Stories
Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow(R) Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis.
Transave, a biopharmaceutical company, has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Company, an affiliate of Horizon Technology Finance Management.
MONMOUTH JUNCTION, N.J., Oct.
Research and Markets (http://www.researchandmarkets.com/research/45fffb/delivering_drugs_b) has announced the addition of the "Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities" report to their offering.
Teleflex Medical, a leading global supplier of disposable products for critical care and surgical applications, has received clearance from the FDA to market the Hudson RCI Neb-U-Mask(R), a respiratory device that allows for the concurrent delivery of aerosolized medication and a high concentration of medical gases to treat acute asthma exacerbations.
MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturday, September 6, PARI Respiratory Equipment will be featured on the Oxygen Network show Today's Family as part of their "Breathe Easier" series.
Kamada has completed a Phase II study with aerosolized alpha-1 antitrypsin, delivered via an optimized eFlow platform nebulizer from PARI Pharma, in cystic fibrosis.
Kamada (TASE: KMDA), a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has completed a Phase II Study with Aerosolized Alpha-1 Antitrypsin (AAT), delivered via an optimized eFlow platform nebulizer (PARI Pharma GmbH), in cystic fibrosis (CF).
By Annie Getsinger, Herald & Review, Decatur, Ill. Jul.
SILVER SPRING, Md., June 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation and its wholly-owned subsidiary, Lung Rx, Inc., announced today the submission of a New Drug Application (NDA) to the U.S.
- Having a loud voice; vociferous; clamorous.
- Of grand or imposing sound.